Overview

Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of continuous interscalene block (CISB) using standard bupivacaine versus a single interscalene injection of liposomal bupivacaine (LB) on pain control following surgical fixation of proximal humerus fractures.
Phase:
Phase 3
Details
Lead Sponsor:
The University of Hong Kong
Treatments:
Bupivacaine